Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome

Cannabis hyperemesis syndrome (CHS) is a clinical syndrome associated with prolonged and regular cannabis use. CHS is characterized by recurrent episodes of intractable nausea and vomiting. Given the overlap with other medical conditions and the frequent delay in diagnosis, finding an effective anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Parvataneni, Swetha, Varela, Lionel, Vemuri-Reddy, Sireesha M, Maneval, Mandy L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682377/
https://www.ncbi.nlm.nih.gov/pubmed/31403013
http://dx.doi.org/10.7759/cureus.4825
_version_ 1783441883559624704
author Parvataneni, Swetha
Varela, Lionel
Vemuri-Reddy, Sireesha M
Maneval, Mandy L
author_facet Parvataneni, Swetha
Varela, Lionel
Vemuri-Reddy, Sireesha M
Maneval, Mandy L
author_sort Parvataneni, Swetha
collection PubMed
description Cannabis hyperemesis syndrome (CHS) is a clinical syndrome associated with prolonged and regular cannabis use. CHS is characterized by recurrent episodes of intractable nausea and vomiting. Given the overlap with other medical conditions and the frequent delay in diagnosis, finding an effective anti-emetic regimen for symptomatic control of CHS can be challenging. We report a case study where aprepitant (Emend) was successfully used as an anti-emetic in the treatment of CHS when all other common anti-emetics failed.
format Online
Article
Text
id pubmed-6682377
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-66823772019-08-09 Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome Parvataneni, Swetha Varela, Lionel Vemuri-Reddy, Sireesha M Maneval, Mandy L Cureus Family/General Practice Cannabis hyperemesis syndrome (CHS) is a clinical syndrome associated with prolonged and regular cannabis use. CHS is characterized by recurrent episodes of intractable nausea and vomiting. Given the overlap with other medical conditions and the frequent delay in diagnosis, finding an effective anti-emetic regimen for symptomatic control of CHS can be challenging. We report a case study where aprepitant (Emend) was successfully used as an anti-emetic in the treatment of CHS when all other common anti-emetics failed. Cureus 2019-06-04 /pmc/articles/PMC6682377/ /pubmed/31403013 http://dx.doi.org/10.7759/cureus.4825 Text en Copyright © 2019, Parvataneni et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Family/General Practice
Parvataneni, Swetha
Varela, Lionel
Vemuri-Reddy, Sireesha M
Maneval, Mandy L
Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome
title Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome
title_full Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome
title_fullStr Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome
title_full_unstemmed Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome
title_short Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome
title_sort emerging role of aprepitant in cannabis hyperemesis syndrome
topic Family/General Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682377/
https://www.ncbi.nlm.nih.gov/pubmed/31403013
http://dx.doi.org/10.7759/cureus.4825
work_keys_str_mv AT parvataneniswetha emergingroleofaprepitantincannabishyperemesissyndrome
AT varelalionel emergingroleofaprepitantincannabishyperemesissyndrome
AT vemurireddysireesham emergingroleofaprepitantincannabishyperemesissyndrome
AT manevalmandyl emergingroleofaprepitantincannabishyperemesissyndrome

Ejemplares similares